MetaQ Trials is a technology-driven clinical trial recruitment platform that leverages artificial intelligence and machine learning to connect patients with relevant clinical trials. The company focuses on solving the 'diversity gap' in clinical research by utilizing data-driven outreach to reach underrepresented populations and streamline the enrollment process for sponsors and CROs. The platform acts as a bridge between healthcare providers, patient communities, and pharmaceutical companies. By automating the screening and matching process, MetaQ Trials aims to reduce the time and cost associated with patient recruitment while ensuring high-quality, protocol-compliant participants for Phase I-IV studies.
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:Clinical Trial Recruitment & Tech
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$2M
Investors:Fusion VC, Private Angel Investors
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Service/Tech Provider)
Modalities:Digital Health Platform, AI/ML Algorithms
Active Trials:45
Trial Phases:Phase 1: 5 | Phase 2: 15 | Phase 3: 20 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Clalit Health Services (Data collaboration), Various Global CROs
COMPETITION
Position:Emerging
Competitors:Antidote.me, Deep 6 AI, StudyKIK, SubjectWell
LEADERSHIP
Key Executives:
Ofir Ben-Izhak - CEO & Founder
Scientific Founders:Ofir Ben-Izhak
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MetaQ Trials. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.